Prevention of ursodeoxycholate hepatotoxicity in the rabbit by conjugation with N-methyl amino acids.
The effect of dietary administration of four different amino acid (N-acyl) conjugates of ursodeoxycholic acid on biliary bile acid composition, liver tests and hepatic morphology by light microscopy was examined in the rabbit. Each group of four to five rabbits received a chow diet supplemented with a single conjugate of ursodeoxycholic acid ursodeoxycholyl-glycine, ursodeoxycholyl-sarcosine, ursodeoxycholyl-taurine or ursodeoxycholyl-N-methyltaurine for 3 wks at a dose of 50 mg/kg/day; a control group received chow alone. After 3 wks of feeding, animals receiving ursodeoxycholyl-glycine or ursodeoxycholyl-taurine had hepatotoxicity associated with abnormal liver tests. Lithocholic acid made up 11% +/- 2.7% of biliary bile acids in the ursodeoxycholyl-glycine and 10% +/- 2.2% in the ursodeoxycholyl-taurine group. In contrast, animals receiving ursodeoxycholyl-sarcosine or ursodeoxycholyl-N-methyltaurine had neither hepatotoxicity nor abnormal liver tests and the proportion of lithocholic acid in biliary bile acids increased much less. Complementary studies showed that ursodeoxycholyl-sarcosine and ursodeoxycholyl-N-methyltaurine were not biotransformed during hepatic transport and were resistant to deconjugation and dehydroxylation in the rabbit. These experiments indicate that the N-methyl amino acid conjugates of ursodeoxycholic acid are nontoxic in the rabbit and resist deconjugation and dehydroxylation. Such resistance decreases formation of lithocholic acid in the colon, thus reducing its accumulation and consequent induction of hepatotoxicity.
Schmassmann
A
A
Department of Medicine, University of California, San Diego, La Jolla 92093.
Hofmann
A F
AF
Angellotti
M A
MA
Ton-Nu
H T
HT
Schteingart
C D
CD
Clerici
C
C
Rossi
S S
SS
Rothschild
M A
MA
Cohen
B I
BI
Stenger
R J
RJ
D000596:Amino Acids / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000494:pharmacology*; D000818:Animals; D001647:Bile Acids and Salts / Q000378:metabolism; D001652:Bile Ducts / Q000378:metabolism; D001711:Biotransformation; D001835:Body Weight / Q000187:drug effects; D002784:Cholesterol / Q000097:blood; D003840:Deoxycholic Acid / Q000031:analogs & derivatives*; D004032:Diet; D006168:Guinea Pigs; D008099:Liver / Q000033:anatomy & histology / Q000187:drug effects* / Q000378:metabolism; D008297:Male; D009929:Organ Size / Q000187:drug effects; D011817:Rabbits; D014580:Ursodeoxycholic Acid / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000506:poisoning*
D000596:Amino Acids; D001647:Bile Acids and Salts; D003840:Deoxycholic Acid; D014580:Ursodeoxycholic Acid; D002784:Cholesterol